{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T09:47:08Z","timestamp":1761126428192,"version":"3.44.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.amjmed.2004.03.006","type":"journal-article","created":{"date-parts":[[2004,5,13]],"date-time":"2004-05-13T09:44:36Z","timestamp":1084441476000},"page":"759-766","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["An Evidence-Based medicine approach to Beta-blocker therapy in patients with cirrhosis"],"prefix":"10.1016","volume":"116","author":[{"given":"Jayant A","family":"Talwalkar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick S","family":"Kamath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2004.03.006_BIB1","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/hep.1840220145","article-title":"The treatment of portal hypertension","volume":"22","author":"D'Amico","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB2","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1055\/s-2007-1007133","article-title":"Pharmacological treatment of portal hypertension","volume":"19","author":"D'Amico","year":"1999","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB3","first-page":"1081","article-title":"Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension","volume":"92","author":"Grace","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB4","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/hep.510280339","article-title":"Portal hypertension and variceal bleeding","volume":"28","author":"Grace","year":"1998","journal-title":"Hepatology"},{"issue":"suppl 3-4","key":"10.1016\/j.amjmed.2004.03.006_BIB5","first-page":"III1","article-title":"UK guidelines on the management of variceal hemorrhage in cirrhotic patients","volume":"46","author":"Jalan","year":"2000","journal-title":"Gut"},{"issue":"suppl 1","key":"10.1016\/j.amjmed.2004.03.006_BIB6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0168-8278(00)80422-5","article-title":"Complications of cirrhosis. I. Portal hypertension","volume":"32","author":"Bosch","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB7","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJM198312223092502","article-title":"Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis","volume":"309","author":"Burroughs","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/hep.1840040301","article-title":"A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis","volume":"4","author":"Lebrec","year":"1984","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB9","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/hep.1840060602","article-title":"Propranolol for the prevention of recurrent variceal hemorrhage","volume":"6","author":"Villeneuve","year":"1986","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB10","first-page":"A10","article-title":"Propranolol et prevention des recidives de rupture de varice oesophagienne du cirhotique","volume":"18","author":"Cerebelaud","year":"1986","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB11","first-page":"41","article-title":"Controlled study of propranolol in the prevention of recurrent hemorrhage in cirrhotic patients","volume":"11","author":"Queuniet","year":"1987","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000199483","article-title":"Nadolol for prevention of variceal rebleeding in cirrhosis","volume":"37","author":"Gatta","year":"1987","journal-title":"Digestion"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB13","first-page":"507","article-title":"Unsichere rezidivprophylaxe von osophagusvarizenblutungen durch propranolol bei leberzirrhotikern","volume":"42","author":"Kobeet","year":"1987","journal-title":"Z Clin Med"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB14","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/hep.1840090315","article-title":"Beta-blockade prevents recurrent gastrointestinal bleeding in well-compensated patients with alcoholic cirrhosis","volume":"9","author":"Colombo","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0676.1989.tb00370.x","article-title":"Randomized controlled study of propranolol for prevention of recurrent esophageal varices bleeding in patients with cirrhosis","volume":"9","author":"Sheen","year":"1989","journal-title":"Liver"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0016-5085(90)91308-S","article-title":"Propranolol in the prevention of recurrent variceal hemorrhage in cirrhotic patients. A controlled trial","volume":"98","author":"Garden","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB17","first-page":"851","article-title":"Propranolol in the prevention of variceal hemorrhage in alcoholic cirrhotic patients","volume":"12","author":"Colman","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB18","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0168-8278(91)90828-Y","article-title":"Prevention of recurrent variceal bleeding in alcoholic cirrhotic patients","volume":"12","author":"Rossi","year":"1991","journal-title":"J Hepatol"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB19","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/gut.49.5.682","article-title":"Improving prognosis following a first variceal haemorrhage over four decades","volume":"49","author":"McCormick","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB20","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0168-8278(97)80047-5","article-title":"Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis","volume":"26","author":"Bernard","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB21","first-page":"63","article-title":"Beta-adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis","volume":"25","author":"Bernard","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB22","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1053\/jhep.2001.29305","article-title":"Propranolol for the prevention of first esophageal variceal hemorrhage","volume":"34","author":"Abraczinskas","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB23","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1056\/NEJM198710013171403","article-title":"Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices","volume":"317","author":"Pascal","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/hep.1840080103","article-title":"Nadolol can prevent the first gastrointestinal bleeding in cirrhotics","volume":"8","author":"Ideo","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB25","first-page":"1395","article-title":"A randomized controlled trial for the prevention of the first upper gastrointestinal bleeding due to portal hypertension in cirrhosis. Sclerotherapy or propranolol versus control groups","volume":"8","author":"Strauss","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB26","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0168-8278(88)80515-4","article-title":"Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis. A randomized trial","volume":"7","author":"Lebrec","year":"1988","journal-title":"J Hepatol"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0168-8278(89)90078-0","article-title":"Propranolol prevents first gastrointestinal bleeding in non-ascitic cirrhotic patients. Final report of a multicenter randomized trial","volume":"9","year":"1989","journal-title":"J Hepatol"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB28","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/hep.1840120624","article-title":"Preventive therapy of first gastrointestinal bleeding in patients with cirrhosis","volume":"12","author":"Andreani","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB29","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/hep.1840130517","article-title":"Propranolol in the prevention of the first hemorrhage from esophagogastric varices","volume":"13","author":"Conn","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB30","first-page":"1016","article-title":"Prophylaxis of first hemorrhage from esophageal varices by sclerotherapy, propranolol or both in cirrhotic patients","volume":"14","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB31","first-page":"114","article-title":"The results of two long-term randomized controlled trials evaluating endoscopic sclerotherapy and propranolol as prophylaxis for variceal bleeding","volume":"23","author":"Van Buuren","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB32","first-page":"453A","article-title":"Beta-blockers in the prevention of aggravation of esophageal varices in patients with cirrhosis and small varices","volume":"28","author":"Merkel","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB33","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJM199105303242202","article-title":"Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices","volume":"324","author":"Poynard","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB34","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/hep.510310210","article-title":"Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis","volume":"31","author":"Merkel","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB35","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1053\/gast.1997.v113.pm9352866","article-title":"Effects of isosorbide-5-mononitrate compared with propranolol on first bleeding and long-term survival in cirrhosis","volume":"113","author":"Angelico","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB36","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1572-0241.2002.05540.x","article-title":"Combined ligation and sclerotherapy versus ligation alone for secondary prophylaxis of esophageal variceal bleeding","volume":"97","author":"Singh","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB37","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1572-0241.2001.03595.x","article-title":"Screening for varices in patients with cirrhosis","volume":"96","author":"Chalasani","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB38","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1053\/jhep.2001.23054","article-title":"A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding","volume":"33","author":"Imperiale","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB39","first-page":"66","article-title":"Long course and prognostic factors of virus-induced cirrhosis of the liver","volume":"92","author":"Gentilini","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB40","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1053\/jhep.2001.21410","article-title":"Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection?","volume":"33","author":"Schepis","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB41","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/00042737-199907000-00011","article-title":"Lack of effect of propranolol in the prevention of large esophageal varices in patients with cirrhosis","volume":"11","author":"Cales","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB42","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1053\/gast.2002.33419","article-title":"Endoscopic screening for varices in cirrhosis","volume":"122","author":"Jensen","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB43","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1055\/s-2007-1007193","article-title":"Survival algorithms and outcome analysis in primary biliary cirrhosis","volume":"17","author":"Pasha","year":"1997","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB44","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/0016-5085(89)90526-X","article-title":"Prospective evaluation of esophageal varices in primary biliary cirrhosis","volume":"96","author":"Gores","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB45","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1478-3231.1999.tb00020.x","article-title":"Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid","volume":"19","author":"Angulo","year":"1999","journal-title":"Liver"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB46","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1111\/j.1572-0241.2001.04692.x","article-title":"Screening for esophageal varices among patients with cirrhosis of the liver","volume":"96","author":"Talwalkar","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB47","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S1089-3261(05)70186-0","article-title":"Natural history of portal hypertension in patients with cirrhosis","volume":"5","author":"de Franchis","year":"2001","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB48","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/0140-6736(91)93125-S","article-title":"Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis","volume":"337","author":"Perez-Ayuso","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB49","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/BF02050064","article-title":"Bleeding from peristomal varices","volume":"34","author":"Fucini","year":"1991","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB50","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0735-1097(99)00383-6","article-title":"Beta-blocker therapy for secondary prevention of myocardial infarction in elderly diabetic patients. Results from the National Cooperative Cardiovascular Project","volume":"34","author":"Chen","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB51","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0168-8278(05)80171-0","article-title":"Diurnal pattern of variceal bleeding in cirrhotic patients","volume":"19","author":"Merican","year":"1993","journal-title":"J Hepatol"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB52","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/hep.1840190309","article-title":"Circadian variations of portal pressure and variceal hemorrhage in patients with cirrhosis","volume":"19","author":"Garcia-Pagan","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB53","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1055\/s-2007-1007130","article-title":"Influence of pharmacological agents on portal hemodynamics","volume":"19","author":"Garcia-Pagan","year":"1999","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB54","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0140-6736(95)91740-3","article-title":"Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal hemorrhage in patients with cirrhosis","volume":"346","author":"Feu","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB55","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1053\/he.2000.6779","article-title":"Predictive value of the variceal pressure response to continued pharmacological therapy in patients with cirrhosis and portal hypertension","volume":"31","author":"Escorsell","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB56","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1053\/gast.2002.35955","article-title":"A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis","volume":"123","author":"Patch","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB57","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/hep.1840070306","article-title":"Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis","volume":"7","author":"Poynard","year":"1987","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB58","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1056\/NEJM198208263070920","article-title":"Gastrointestinal bleeding after abrupt cessation of propranolol administration in cirrhosis","volume":"307","author":"Lebrec","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2004.03.006_BIB59","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0168-8278(86)80143-X","article-title":"Haemodynamic rebound phenomena after abrupt cessation of propranolol therapy in portal hypertensive rats","volume":"3","author":"Lee","year":"1986","journal-title":"J Hepatol"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934304002104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934304002104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:28:41Z","timestamp":1757579321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934304002104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":59,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S0002934304002104"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2004.03.006","relation":{},"ISSN":["0002-9343"],"issn-type":[{"type":"print","value":"0002-9343"}],"subject":[],"published":{"date-parts":[[2004,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An Evidence-Based medicine approach to Beta-blocker therapy in patients with cirrhosis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2004.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Excerpta Medica Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}